Pharmaceutical drug products
Active Awarded
- Contract number
- 75F40125F19010
- Awardee
-
We Pharma, Inc. UEI EWAMVJSFNK29
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $75,000
Award facts
- Contract value 100% obligated
- $75,000.00 Current and potential, with all options
- Completion date 97% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Two Step
- Pricing
- Firm Fixed Price
- Place of performance
- Silver Spring, MD 20903, USA
Award details come from SAM.gov/FPDS.
About this award
The Food and Drug Administration has awarded a $75,000 firm fixed-price delivery order to We Pharma, Inc. (doing business as WEP Clinical) for the supply of pharmaceutical drug products. This non-set-aside contract, effective through November 13, 2026, represents a discrete task order under one of the company's existing Indefinite Delivery Indefinite Quantity (IDIQ) contracts with the FDA. Performance will take place in Silver Spring, Maryland, where the FDA maintains significant research and regulatory operations. We Pharma, a small disadvantaged business registered in North Carolina since 2015, has demonstrated consistent capability in supplying pharmaceutical products to federal agencies and holds two substantial IDIQ vehicles with the FDA valued at $9.5 million and $6 million respectively.
We Pharma's contract history with the FDA reflects specialization in supporting the agency's regulatory science initiatives, including the Generic Drug User Fee Amendments program and the Office of Pharmaceutical Quality Research. The company's existing IDIQ contracts require maintenance of an annually updated pharmaceutical pricing list and provision of emergency overnight delivery services across multiple FDA locations. This delivery order award reflects the contractor's established performance record and competitive positioning within the federal pharmaceutical supply market for civilian government agencies.
Quick answers
Who was awarded contract 75F40125F19010?
75F40125F19010 was awarded to We Pharma, Inc. by Food and Drug Administration (Department of Health and Human Services) on May 14, 2025.
How much is contract 75F40125F19010 worth?
The government has obligated $75,000 on 75F40125F19010.
Is contract 75F40125F19010 an order under another contract?
Yes. 75F40125F19010 is a delivery order under 75F40120D00032, an indefinite delivery contract.
Was contract 75F40125F19010 competed?
The extent of competition for 75F40125F19010 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award